The idea of the Doha Declaration was background by the protest of the developing countries who think the TRIPS Safeguards is not clear and not multi interpretation. The developing countries are trying to find a interpretation instrument to the TRIPS Safeguards that fulfill the requirements of International law, especially the Vienna Convention which set the Treaty Law and the negotiation legislative process based on the WTO decision making framework. In Doha Declaration, the developing countries reach the main purpose to find the explanation to the TRIPS Safeguards interpretation. Even in the future, the difference of the economic level, technology, and the interests of the developing countries will be the one to trigger the debate of the p...
Access to medicines is a human right, enshrined in legally binding international human rights treati...
In 2001 the Declaration on the TRIPS Agreement and Public Health (‘Doha Declaration’), affirmed the ...
Abstract There are acute disparities in pharmaceutical access between developing and i...
The idea of the Doha Declaration was background by the protest of the developing countries who think...
401-413Adhering to the TRIPS Agreement in the pharmaceutical sector poses several questions before d...
Is access to medicines at risk despite the Doha Declaration? What are the alternative mechanisms tha...
Paragraph 6 of the Doha Declaration on Public Health, dealing with access to medicines for countries...
The World Trade Organization ( WTO ) Trade-Related Aspects of Intellectual Property Rights Agreement...
At the World Trade Organization Ministerial Conference in Doha, a number of key declarations were ma...
Abstract The stated purpose of intellectual property protection is to stimulate innovation. The Agre...
This article critically analyzes the agreement implementing Paragraph 6 of the Doha Declaration. The...
This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Journal of...
International audienceHarmonization of intellectual property rights among WTO members in the recent ...
This entry into force of the World Trade Organization (WTO) TRIPS Agreement in 1995 transformed the ...
BACKGROUND: The World Trade Organisation's Declaration on the TRIPS Agreement and Public Health (kno...
Access to medicines is a human right, enshrined in legally binding international human rights treati...
In 2001 the Declaration on the TRIPS Agreement and Public Health (‘Doha Declaration’), affirmed the ...
Abstract There are acute disparities in pharmaceutical access between developing and i...
The idea of the Doha Declaration was background by the protest of the developing countries who think...
401-413Adhering to the TRIPS Agreement in the pharmaceutical sector poses several questions before d...
Is access to medicines at risk despite the Doha Declaration? What are the alternative mechanisms tha...
Paragraph 6 of the Doha Declaration on Public Health, dealing with access to medicines for countries...
The World Trade Organization ( WTO ) Trade-Related Aspects of Intellectual Property Rights Agreement...
At the World Trade Organization Ministerial Conference in Doha, a number of key declarations were ma...
Abstract The stated purpose of intellectual property protection is to stimulate innovation. The Agre...
This article critically analyzes the agreement implementing Paragraph 6 of the Doha Declaration. The...
This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Journal of...
International audienceHarmonization of intellectual property rights among WTO members in the recent ...
This entry into force of the World Trade Organization (WTO) TRIPS Agreement in 1995 transformed the ...
BACKGROUND: The World Trade Organisation's Declaration on the TRIPS Agreement and Public Health (kno...
Access to medicines is a human right, enshrined in legally binding international human rights treati...
In 2001 the Declaration on the TRIPS Agreement and Public Health (‘Doha Declaration’), affirmed the ...
Abstract There are acute disparities in pharmaceutical access between developing and i...